ID   CL1-5-F4
AC   CVCL_IN56
SY   CL 1-5-F 4; CL1-5F4; F4
DR   BTO; BTO:0006343
DR   GEO; GSM185876
DR   Wikidata; Q54813514
RX   PubMed=11431363;
RX   PubMed=19597463;
RX   PubMed=24705471;
RX   PubMed=25060522;
CC   Population: Chinese; Taiwan.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D521 ! CL1-5
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 29-06-23; Version: 7
//
RX   PubMed=11431363;
RA   Chen J.J.W., Peck K., Hong T.-M., Yang S.-C., Sher Y.-P., Shih J.-Y.,
RA   Wu R., Cheng J.-L., Roffler S.R., Wu C.-W., Yang P.-C.;
RT   "Global analysis of gene expression in invasion by a lung cancer
RT   model.";
RL   Cancer Res. 61:5223-5230(2001).
//
RX   PubMed=19597463; DOI=10.1038/onc.2009.187;
RA   Sher Y.-P., Tzeng T.-F., Kan S.-F., Hsu J.L., Xie X., Han Z., Lin W.-C.,
RA   Li L.-Y., Hung M.-C.;
RT   "Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer
RT   growth and improves long-term survival.";
RL   Oncogene 28:3286-3295(2009).
//
RX   PubMed=24705471; DOI=10.1371/journal.pone.0094065;
RA   Sher Y.-P., Wang L.-J., Chuang L.-L., Tsai M.-H., Kuo T.-T.,
RA   Huang C.-C., Chuang E.Y., Lai L.-C.;
RT   "ADAM9 up-regulates N-cadherin via miR-218 suppression in lung
RT   adenocarcinoma cells.";
RL   PLoS ONE 9:E94065-E94065(2014).
//
RX   PubMed=25060522; DOI=10.1158/0008-5472.CAN-13-2995;
RA   Lin C.-Y., Chen H.-J., Huang C.-C., Lai L.-C., Lu T.-P., Tseng G.-C.,
RA   Kuo T.-T., Kuok Q.-Y., Hsu J.L., Sung S.-Y., Hung M.-C., Sher Y.-P.;
RT   "ADAM9 promotes lung cancer metastases to brain by a plasminogen
RT   activator-based pathway.";
RL   Cancer Res. 74:5229-5243(2014).
//